RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sernova Biotherapeutics Stock

Sernova Biotherapeutics Revenue 2025

Sernova Biotherapeutics Revenue

10.1 M CAD

Ticker

SVA.TO

ISIN

CA81752F1062

WKN

A0LBCR

In 2025, Sernova Biotherapeutics's sales reached 10.1 M CAD, a 0% difference from the 0 CAD sales recorded in the previous year.

The Sernova Biotherapeutics Revenue history

YEARREVENUE (undefined CAD)GROSS MARGIN (%)
2030e290.27-
2029e120.51-
2028e126.71-
2027e53.04-
2026e0.2-
2025e10.1-
2024--
2023--
2022--
2021--
2020--
2019--
2018--
2017--
2016--

Sernova Biotherapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sernova Biotherapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sernova Biotherapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sernova Biotherapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sernova Biotherapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sernova Biotherapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sernova Biotherapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sernova Biotherapeutics’s growth potential.

Sernova Biotherapeutics Revenue, EBIT and net profit per share

DateSernova Biotherapeutics RevenueSernova Biotherapeutics EBITSernova Biotherapeutics Net Income
2030e290.27 M undefined0 undefined136.88 M undefined
2029e120.51 M undefined0 undefined49.63 M undefined
2028e126.71 M undefined491.46 M undefined54.16 M undefined
2027e53.04 M undefined81.71 M undefined-13.95 M undefined
2026e202,333.3 undefined-43.83 M undefined-17.05 M undefined
2025e10.1 M undefined-21.11 M undefined-10.85 M undefined
20240 undefined-31.66 M undefined-32.19 M undefined
20230 undefined-40.5 M undefined-39 M undefined
20220 undefined-24.75 M undefined-24.42 M undefined
20210 undefined-6.94 M undefined-6.97 M undefined
20200 undefined-5.26 M undefined-5.32 M undefined
20190 undefined-4.01 M undefined-3.97 M undefined
20180 undefined-3.71 M undefined-3.7 M undefined
20170 undefined-2.64 M undefined-2.64 M undefined
20160 undefined-2.5 M undefined-2.5 M undefined

Sernova Biotherapeutics stock margins

The Sernova Biotherapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sernova Biotherapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sernova Biotherapeutics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sernova Biotherapeutics's sales revenue. A higher gross margin percentage indicates that the Sernova Biotherapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sernova Biotherapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sernova Biotherapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sernova Biotherapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sernova Biotherapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sernova Biotherapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sernova Biotherapeutics Margin History

Sernova Biotherapeutics Gross marginSernova Biotherapeutics Profit marginSernova Biotherapeutics EBIT marginSernova Biotherapeutics Profit margin
2030e0 %0 %47.15 %
2029e0 %0 %41.19 %
2028e0 %387.86 %42.74 %
2027e0 %154.06 %-26.3 %
2026e0 %-21,664.25 %-8,427.34 %
2025e0 %-209 %-107.43 %
20240 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %

Sernova Biotherapeutics Aktienanalyse

What does Sernova Biotherapeutics do?

Sernova Biotherapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Sernova Biotherapeutics's Sales Figures

The sales figures of Sernova Biotherapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Sernova Biotherapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Sernova Biotherapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Sernova Biotherapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Sernova Biotherapeutics stock

How much revenue did Sernova Biotherapeutics generate this year?

Sernova Biotherapeutics has achieved a revenue of 10.1 M CAD this year.

How much was the turnover of the company Sernova Biotherapeutics compared to the previous year?

The revenue of Sernova Biotherapeutics has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Sernova Biotherapeutics?

The revenue of Sernova Biotherapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Sernova Biotherapeutics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Sernova Biotherapeutics so important for investors?

The revenue of Sernova Biotherapeutics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Sernova Biotherapeutics pay?

Over the past 12 months, Sernova Biotherapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sernova Biotherapeutics is expected to pay a dividend of 0 CAD.

What is the dividend yield of Sernova Biotherapeutics?

The current dividend yield of Sernova Biotherapeutics is .

When does Sernova Biotherapeutics pay dividends?

Sernova Biotherapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sernova Biotherapeutics?

Sernova Biotherapeutics paid dividends every year for the past 0 years.

What is the dividend of Sernova Biotherapeutics?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sernova Biotherapeutics located?

Sernova Biotherapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sernova Biotherapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sernova Biotherapeutics from 5/21/2025 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 5/21/2025.

When did Sernova Biotherapeutics pay the last dividend?

The last dividend was paid out on 5/21/2025.

What was the dividend of Sernova Biotherapeutics in the year 2024?

In the year 2024, Sernova Biotherapeutics distributed 0 CAD as dividends.

In which currency does Sernova Biotherapeutics pay out the dividend?

The dividends of Sernova Biotherapeutics are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sernova Biotherapeutics

Our stock analysis for Sernova Biotherapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sernova Biotherapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.